Apollo Endosurgery market cap is $120.9 m, and annual revenue was $42.05 m in FY 2020

Apollo Endosurgery Gross profit (FY, 2020)22.2 M

Apollo Endosurgery Gross profit margin (FY, 2020), %52.9%

Apollo Endosurgery Net income (FY, 2020)-22.6 M

Apollo Endosurgery EBIT (FY, 2020)-15.8 M

Apollo Endosurgery Cash, 31-Dec-202036.2 M

Apollo Endosurgery EV141.9 M

Apollo Endosurgery revenue was $42.05 m in FY, 2020

Apollo Endosurgery revenue breakdown by business segment: 55.8% from Endoscopic Suturing System, 33.2% from Intragastric Balloon, 7.3% from Surgical and 3.7% from Other

Apollo Endosurgery revenue breakdown by geographic segment: 43.2% from US and 56.8% from Non US

USD | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 |
---|---|---|---|---|

## Revenue | 64.3m | 60.9m | 50.7m | 42.0m |

| (5%) | (17%) | ||

## Cost of goods sold | 24.6m | 27.7m | 25.0m | 19.8m |

## Gross profit | 39.7m | 33.2m | 25.7m | 22.2m |

| 62% | 55% | 51% | 53% |

## Sales and marketing expense | 32.9m | 32.8m | 28.7m | 17.4m |

## R&D expense | 8.3m | 12.2m | 10.4m | 7.7m |

## General and administrative expense | 13.7m | 13.4m | 13.6m | 11.1m |

## Operating expense total | 62.2m | 73.3m | 49.2m | 38.0m |

## Depreciation and amortization | 7.2m | 7.1m | 2.1m | 1.9m |

## EBIT | (22.4m) | (40.1m) | (23.5m) | (15.8m) |

| (35%) | (66%) | (46%) | (38%) |

## Interest expense | 4.5m | 4.1m | 4.1m | 5.3m |

## Pre tax profit | (27.0m) | (45.6m) | (27.2m) | (22.5m) |

## Income tax expense | 304.0k | 191.0k | 275.0k | 142.0k |

## Net Income | (27.3m) | (45.8m) | (27.4m) | (22.6m) |

## EPS | (2.0) | (2.3) | (1.3) |

USD | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 |
---|---|---|---|---|

## Cash | 30.5m | 24.0m | 29.9m | 36.2m |

## Accounts Receivable | 11.7m | 11.4m | 9.2m | 8.2m |

## Prepaid Expenses | 1.0m | 2.8m | 3.0m | 3.8m |

## Inventories | 14.3m | 9.9m | 8.9m | 10.3m |

## Current Assets | 57.6m | 48.1m | 51.0m | 58.5m |

## PP&E | 6.9m | 5.9m | 6.6m | |

## Goodwill | 6.8m | 5.3m | 5.3m | 5.3m |

## Total Assets | 109.1m | 74.5m | 74.6m | 77.4m |

## Accounts Payable | 18.3m | 15.3m | 9.9m | 3.7m |

## Short-term debt | 34.4m | 636.0k | ||

## Current Liabilities | 25.8m | 24.4m | 52.8m | 11.7m |

## Long-term debt | 33.3m | 21.2m | 18.6k | 56.6m |

## Total Debt | 33.3m | 21.2m | 34.5m | 57.2m |

## Total Liabilities | 59.1m | 45.6m | 72.5m | 70.7m |

## Common Stock | 17.0k | 22.0k | 21.0k | 26.0k |

## Additional Paid-in Capital | 225.1m | 249.1m | 250.6m | 276.6m |

## Retained Earnings | (177.0m) | (222.8m) | (250.2m) | (272.8m) |

## Total Equity | 49.9m | 28.8m | 2.1m | 6.8m |

## Debt to Equity Ratio | 0.7 x | 0.7 x | 16.2 x | |

## Debt to Assets Ratio | 0.3 x | 0.3 x | 0.5 x | |

## Financial Leverage | 2.2 x | 2.6 x | 35.1 x | 11.5 x |

USD | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 |
---|---|---|---|---|

## Net Income | (27.3m) | (45.8m) | (27.4m) | (22.6m) |

## Depreciation and Amortization | 9.7m | 9.3m | 4.1m | |

## Accounts Receivable | (916.0k) | (162.0k) | 1.9m | 1.1m |

## Inventories | (2.8m) | 3.0m | 872.0k | (1.6m) |

## Accounts Payable | 4.7m | (1.3m) | (2.1m) | (7.1m) |

## Cash From Operating Activities | (13.3m) | (23.1m) | (25.6m) | (20.8m) |

## Purchases of PP&E | (1.6m) | (2.0m) | (805.0k) | (486.0k) |

## Cash From Investing Activities | (2.1m) | 7.1m | 1.0m | 1.4m |

## Long-term Borrowings | (7.0m) | (12.5m) | (21.7m) | |

## Cash From Financing Activities | 26.7m | 9.7m | 30.5m | 25.6m |

## Net Change in Cash | 11.4m | (6.4m) | 5.9m | 6.3m |

## Interest Paid | 3.8m | 3.8m | 3.5m | 3.2m |

## Income Taxes Paid | 274.0k | 98.0k | 328.0k | 192.0k |

USD | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
---|---|---|---|---|---|---|---|---|---|

## Net Income | (8.1m) | (17.7m) | (27.4m) | (2.8m) | (11.6m) | (20.2m) | (10.3m) | (16.5m) | (19.1m) |

## Depreciation and Amortization | 2.4m | 4.7m | 7.0m | 1.1m | 2.2m | 3.1m | 955.0k | 1.9m | 2.8m |

## Accounts Receivable | 62.0k | (90.0k) | 1.1m | 790.0k | 117.0k | 2.1m | 1.4m | 3.3m | 930.0k |

## Inventories | (1.2m) | (1.0m) | 439.0k | (502.0k) | (659.0k) | (1.0m) | (1.5m) | (2.3m) | (1.3m) |

## Accounts Payable | 272.0k | (3.7m) | (3.0m) | 1.6m | 1.6m | 97.0k | 15.0k | (4.6m) | (7.3m) |

## Cash From Operating Activities | (6.7m) | (16.2m) | (18.9m) | (6.1m) | (12.7m) | (18.9m) | (6.3m) | (13.3m) | (18.0m) |

## Purchases of PP&E | (1.2m) | (1.5m) | (2.0m) | (112.0k) | (377.0k) | (466.0k) | (272.0k) | (388.0k) | (431.0k) |

## Cash From Investing Activities | (1.3m) | (1.9m) | (2.7m) | (177.0k) | (458.0k) | (629.0k) | (318.0k) | (458.0k) | (548.0k) |

## Long-term Borrowings | (2.5m) | (21.7m) | (21.7m) | (21.7m) | |||||

## Cash From Financing Activities | (250.0k) | 22.2m | 19.7m | 12.2m | 12.1m | 30.6m | (206.0k) | 2.6m | 25.8m |

## Net Change in Cash | (8.2m) | 4.0m | (2.0m) | 6.0m | (1.1m) | 11.0m | (6.9m) | (11.2m) | 7.3m |

## Interest Paid | 889.0k | 1.8m | 2.7m | 1.2m | 1.8m | 2.6m | 814.0k | 1.6m | 2.4m |

## Income Taxes Paid | 14.0k | 42.0k | 36.0k | 32.0k | 132.0k | 7.0k | 13.0k | 52.0k |

USD | FY, 2017 |
---|---|

## Revenue/Employee | 302.0k |

## Debt/Equity | 0.7 x |

## Debt/Assets | 0.3 x |

## Financial Leverage | 2.2 x |